Korea

Lunit and Agfa HealthCare bring breast imaging AI solution to Dubai Academic Health Corporation (DAHC) Dubai Hospital

* Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnostic and Screening program with Agfa HealthCare's RUBEE for AI framework and Lunit INSIGHT MMG algorithm * The Breast AI Analysis Package is Lunit's first application with Agfa HealthCare since form...

2023-02-08 21:05 3156

SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center

* The additional investment for the 'R&PD Center' was confirmed by the board of directors committee with a total of261 million USD * SK bioscience plans to establish a vaccine-biopharmaceutical hub, organizing a global cooperative model against new pandemics SEONGNAM, South Korea, Feb. 8, 202...

2023-02-08 20:00 3025

J INTS BIO, Oral TKI 'JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC

SEOUL, South Korea, Feb. 6, 2023 /PRNewswire/ -- J INTS BIO announced that the preclinical results of "JIN-A04," a novel oral tyrosine kinase inhibitor (TKI) targeting HER2 Exon20 insertion mutation in NSCLC, will be presented at the upcoming 2023 American Cancer Research Association meeting inOr...

2023-02-07 12:23 1710

NAVER Z celebrates Safer Internet Day 2023 in collaboration with ConnectSafely

SEONGNAM, South Korea, Feb. 6, 2023 /PRNewswire/ -- In honor of Safer Internet Day 2023 , NAVER Z collaborated with ConnectSafely for their Family Program to highlight ZEPETO's approach to safety and raise awareness on how to stay saf...

2023-02-06 22:00 2385

Daewoong Pharmaceutical begins the first administration of the Bersiporocin, new treatment for idiopathic pulmonary fibrosis, as Phase II clinical trial

- Evaluation of Bersiporocin's safety and efficacy against a total of 102 patients over 24 weeks - Development of treatment for pulmonary fibrosis which is unsatisfactory and in high demand, and anticipation for extended adaptability against various rare fibrosis diseases SEOUL, South Korea, Fe...

2023-02-06 13:00 2480

OURHOME Global Chefs' Special Meal Campaign Serving a special menu every month around the world

* Serve a special menu to stores in 5 countries including Korea, U.S., China, Poland and Vietnam * With its standardized recipes, realized local taste and quality anywhere in the world * Starting with Korean 'Tteokguk' in January, planning to serve Chinese 'Jingjiang Lou Si' in February, an...

2023-02-03 21:00 4708

LG Innotek accelerates FC-BGA as the Global No.1 Business

* New FC-BGA Substrate unveiled in the CES 2023 * 1st Significant production achieved in last year, Full-Scale Production will be possible in the 2nd half of this this year * CEO Jeong Cheol-dong "Enabling Global No.1 FC-BGA by Creating Differentiated Customer Value." SEOUL, South Korea, Feb...

2023-02-02 22:00 4497

Premium vegan brand, d'Alba, with new launches

SEOUL, South Korea, Feb. 1, 2023 /PRNewswire/ -- d'Alba, the premium vegan skincare brand, is growing in the US market. Inspired by Alba, Piedmont inItaly . Alba is a World Heritage site known for their finest white truffles. d'Alba chose white truffles from Alba as d'Alba's signature ingredient. ...

2023-02-01 22:00 7714

HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update

* Full-Year 2022 net revenue of KRW 110 billion, up 8% over 2021 reaching a record high * Strong R&D momentum to continue with batoclimab entering multiple pivotal studies with the first Phase 3 data readout inChina expected in 2023 * Top-line data from tanfanercept's Phase 3 dry eye study e...

2023-02-01 20:00 2542

SK D&D Episode, Publication of First Global Coliving Trend Report

More than 78% of respondents say they want a "new experience" more than economic benefit * Worldwide Coliving Membership (WCM), which is operated and established by SK D&D Episode has published its first project, the Flexible Living Trend Report 2023 Vol. 1 * Survey of coliving space residen...

2023-02-01 08:00 2403

SK hynix Reports 2022 and Fourth Quarter Financial Results

* FY2022 revenues at 44.648 trillion won, operating profit at 7.007 trillion won * First operating loss in 10 years in 4Q due to sluggish demand, price fall of memory chips * "Preparedness for new market based on technological competitiveness expected to lead to quick turnaround in earnings...

2023-02-01 07:12 4280

Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection

* Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC * Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other technology tools that enhance Guardant Health's portfolio of...

2023-01-31 21:05 3048

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

* SK bioscience shared a development history of the South Korea's first COVID-19 vaccine at the Riyadh Global Medical Biotechnology Summit 2023 (RGBMS 2023) in theKingdom of Saudi Arabia(KSA) * SK bioscience also explained a new global partnership model aiming to promote public health in deve...

2023-01-27 20:00 4998

Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

* Q4'22 consolidated revenue of KRW 965.5 billion and Q4'22 operating profit ofKRW 312.8 billion. * FY'22 consolidated revenue of KRW 3.00 trillion and FY'22 operating profit ofKRW 983.6 billion. * Strong growth momentum expected to continue with active expansions in capacity, geography, an...

2023-01-27 14:52 4479

LG Energy Solution Posts 2022 Earnings with Record-High Annual Revenue and Operating Profit

* LGES marks KRW 25.6 trillion in consolidated revenue and KRW 1.2 trillion in operating profit in 2022 * 2023 goal set at 25-30 percent increase in annual revenue, with over 50 percent increase in capital expenditure * The company to concentrate on four key initiatives to respond to the ris...

2023-01-27 09:30 3977

SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane

* First Generic of Abraxane in Korea, World 4th Commercial Scale-Up * Global tech-transfer expected to US, Japan, and Europe SEONGNAM, South Korea ,Jan. 26, 2023 /PRNewswire/ -- SN BioScience (CEO Park Young-hwan) and Boryeong (CEOJang Doo-hyun) signed a domestic manufacturing technology transf...

2023-01-26 14:31 2950

iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax

* Confirmed antibacterial efficacy against a variety of anthrax strains including the one used in the 2001 anthrax attack * Provides the most potent bactericidal ability that no other PEP antibiotics in the market can exhibit * Further developments are planned to conduct with a licensing/col...

2023-01-26 10:34 2535

SK hynix Develops World's Fastest Mobile DRAM LPDDR5T

* Data transmission speed increases by 13%, with improved energy-efficiency * Application of HKMG process to DRAM maximizes product performance * "SK hynix to spur technology development, aiming to be industry's game changer" SEOUL, South Korea, Jan. 24, 2023 /PRNewswire/ -- SK hynix Inc. (or...

2023-01-25 07:00 3860

SK bioscience Appoints New Executives to Accelerate New Growth Strategies

* Two biopharmaceutical experts join SK bioscience to strengthen the future strategies * With recruitment of global talent and capabilities accumulated during the COVID-19 pandemic, SK bioscience will continue to achieve sustainable growth SEOUL, South Korea, Jan. 20, 2023 /PRNewswire/ -- SK ...

2023-01-20 20:00 3934

Industrial AI Company ONEPREDICT Appoints COO to Expand Global Business and Lead its New US Entity

-  ONEPREDICT Incorporated its first overseas entity in San Francisco, US, to expand global customer touchpoints. -  Bharat Vats, an AI/IoT business thought leader and senior executive, has been named as the newly-created Chief Operating Officer (COO) and Chief Growth Officer (CGO) role to solid...

2023-01-19 22:00 3807
1 ... 100101102103104105106 ... 141